extraction technology Qiagen Looks to Convert Pandemic Sales Surge Into Long-Term Growth Premium COVID-19 accelerated the growth of several product portfolios, but under CEO Thierry Bernard, the company is ready to put the pandemic behind it — mostly. Cellular Analytics Eyes Drug Development Space with Circulating Tumor Cell Capture Platform Premium Emerging from stealth mode, the Toronto-based firm will use the platform to identify circulating tumor cells and spur drug development in the lung cancer space. Baylor Genetics, Miraca Research Institute Explore EV Purification for Cancer-Based Applications Premium The group will validate Miraca's prototype extracellular vesicle isolation tool and antibody reagents using blood samples from breast and pancreatic patients. Optofluidic Chip Integrates Nanopores, Electrical Feedback to Control Single-Molecule Delivery Premium Researchers have launched a startup called Fluxus to commercialize a platform based on the optofluidic chip for molecular analysis. Caliper Completes Divestiture of Product Lines to Biotage The firm also released pro forma results for its Q1 — reflecting the dispositions of the specialty product lines — showing $2.1 million less in revenues than previously reported, while its cash position increased 45 percent. Apr 17, 2009 Qiagen Licenses HandyLab Extraction Technology Mar 3, 2009 LC Sciences Joins Agilent, NimbleGen, Febit, and Others in the Nascent Target Enrichment Market Premium Feb 17, 2009 Febit Plans to Launch HybSelect App in March in Bid to Tap Seq-Capture Market Premium Breaking News 23andMe Fiscal Q4 Revenues Increase 14 Percent Local Coverage Determinations Roundup: Castle Bio, SkylineDx Ancient Genome Sequence Provides Look at Ancestry for Individual Who Perished at Pompeii Allogeneic Stem Cell Transplant Outcomes Improve With Diverse Gut Microbes, Immune Cells CorePath Laboratories, Cizzle Biotechnology Partner on Lung Cancer Blood Test Becton Dickinson Gets CE-IVD Mark for High-Throughput COVID/Flu PCR Test The Scan Billion-Dollar Diversity Initiative The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce. Biotech Co-Founder Arrested A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News. Return of the Tasmanian Tiger The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction. Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.